Primary photodynamics of a biomimetic model of photoactive yellow protein (PYP)
文献情報
Pascale Changenet-Barret, Christina Loukou, Christian Ley, Fabien Lacombat, Pascal Plaza, Jean-Maurice Mallet, Monique M. Martin
The present work aims at characterizing the photophysical behavior of a first biomimetic cyclodextrin model (CD-PYP1) of the photoactive site of photoactive yellow protein (PYP). The hydrophobic cyclodextrin cavity in which the chromophore self-includes, mimics its local environment within the protein. The photoinduced behavior of deprotonated CD-PYP1 (dp-CD-PYP1) has been probed by femtosecond transient-absorption spectroscopy and compared to those of the free deprotonated chromophore (pCT−) and of wild-type PYP. The excited-state deactivation of dp-CD-PYP1 is found to be non-exponential, with slower time components and higher quantum yield of fluorescence than pCT−. Like in PYP, the non-exponential decay is attributed to ground-state structural heterogeneities of the self-inclusion complexes. A long-lived photoproduct is observed in the transient spectra of dp-CD-PYP1 and identified as the cis isomer. The isomerization quantum yield of dp-CD-PYP1 is estimated to be about 4%, in contrast with the free chromophore in solution which does not photoisomerize at all. This demonstrates the active role of the cyclodextrin environment to promote the photoisomerization of the chromophore, as is thought to be the case for wild-type PYP. The effects of chromophore inclusion in the cyclodextrin on the photoinduced processes are rationalized within the framework of recent theoretical calculations involving two competitive deactivation channels: (i) trans to cis isomerization and (ii) rotation of the phenolate group, leading to trans ground-state recovery. Inclusion is proposed to favor isomerization by hindering the rotation of the phenolate group. Optimizing the structure of this first model in order to better reproduce the primary photoresponse of PYP thus appears very promising.
関連文献
Antinociceptive activity of thiazole-containing cyclized DAMGO and Leu-(Met) enkephalin analogs
Hannah M. Harris, Shainnel O. Eans, Michelle L. Ganno, Jennifer C. Davis, Colette T. Dooley, Jay P. McLaughlin, Adel Nefzi
DOI: 10.1039/C9OB00882A
Fluorescence-labeled neopeltolide derivatives for subcellular localization imaging
Shota Yanagi, Tomoya Sugai, Takuma Noguchi, Masato Kawakami, Makoto Sasaki, Shinsuke Niwa, Asako Sugimoto, Haruhiko Fuwa
DOI: 10.1039/C9OB01276A
Phosphine-catalyzed dearomative (3 + 2) annulation of 2-nitrobenzofurans and nitrobenzothiophenes with allenoates
Jian-Qiang Zhao, Lei Yang, Yong You, Zhen-Hua Wang, Ke-Xin Xie, Xiao-Mei Zhang, Xiao-Ying Xu, Wei-Cheng Yuan
DOI: 10.1039/C9OB00775J
Dinuclear zinc synergistic catalytic asymmetric phospha-Michael/Michael cascade reaction: synthesis of 1,2,3-trisubstituted indanes bearing phosphoryl groups
Bing-Kai Tao, Hua Yang, Yuan-Zhao Hua, Min-Can Wang
DOI: 10.1039/C9OB00544G
A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation
Alexandra Pastor, Arnaud Machelart, Xue Li, Nicolas Willand, Alain Baulard, Priscille Brodin, Ruxandra Gref, Didier Desmaële
DOI: 10.1039/C9OB00680J
Late-stage C–H amination of abietane diterpenoids
Alejandro Dana, Pablo H. Di Chenna, Benjamin Darses, Fernando J. Durán, Philippe Dauban
DOI: 10.1039/C9OB00272C
Synthesis of macrocyclic peptidomimetics via the Ugi-click-strategy
Elena A. Zakharova, Olga I. Shmatova, Irina V. Kutovaya, Valentine G. Nenajdenko
DOI: 10.1039/C9OB00229D
Direct access to bis-S-heterocycles via copper-catalyzed three component tandem cyclization using S8 as a sulfur source
Peiqi Zhou, Yubing Huang, Wanqing Wu, Wentao Yu, Jianxiao Li, Zhongzhi Zhu, Huanfeng Jiang
DOI: 10.1039/C9OB00377K
Synthesis of vicinal dideoxy-difluorinated galactoses
Julien Malassis, Jean-Baptiste Vendeville, Qui-Hien Nguyen, Marie Boujon, Quentin Gaignard-Gaillard, Mark Light, Bruno Linclau
DOI: 10.1039/C9OB00707E
こちらもおすすめ
2,5-二羧基氟苯の市場動向や研究トレンドはどうですか?
2,5-二羧基氟苯の市場は、主に医薬品および農薬の研究開発において伸長しています。一方、環境への影響や安全性の懸念から、その使用は一定の制限が置かれています。今...
8-甲基-2-噻吩-2-基-喹啉-4-羧酸を含む廃棄物はどのように処理すべきですか?
8-甲基-2-噻吩-2-基-喹啉-4-羧酸を含む廃棄物は専門的な廃棄処理が必要です。具体的には、廃棄物は密閉の容器に収集し、適切な危険物対策を講じて専門業者に引...
2-(1,3-二氧杂烷-2-基)噻唑の物理化学的性質は何ですか?
CAS番号24295-04-3の2-(1,3-二氧杂烷-2-基)噻唑は、結晶形態により白色粉末を呈します。分子量は208.23 g/molであり、水に溶けにくい...
L-beta-高酪氨酸塩酸塩は安全ですか?
L-beta-高酪氨酸塩酸塩自体は毒性は低く、しかし使用する際は適切な個人保護具を使用し、誤飲や皮膚への接触を避けることが推奨されます。
睡茄灯笼草素Cはどのように合成されますか?
睡茄灯笼草素Cは、シクラメンケチャナfromaceaeから抽出する方法や、化学合成法で合成することができます。典型的な化学合成法では、3β,22-二オキシエクス...
4-(嘧啶-2-基)哌嗪-1-羧酸叔丁酯はどのように保存すればよいですか?
4-(嘧啶-2-基)哌嗪-1-羧酸叔丁酯は直射日光を避けて、室温で保存するのが良いです。湿度を避けて密閉容器に入れて保管し、未使用の状態で長期保存することができ...
NBI-74330の主な用途は何ですか?
NBI-74330は主に薬理学研究および医療用途に使用されています。その主な用途は抗がん作用を有するため、がん治療の研究に使用されています。
6-トリフルオロメチル-2-クロロピリジン-4-ボリリック酸はどのように合成されますか?
6-トリフルオロメチル-2-クロロピリジン-4-ボリリック酸は、6-トリフルオロメチル-2-クロロピリジンとボリルリチウムを触媒なしで反応させることで合成するこ...
掲載誌
Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.











![2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole structure 2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole structure](https://static.chemtradehub.com/structs/122/1226781-80-1-09d5.webp)


